New pill aims to boost fetal hemoglobin in sickle cell patients
Disease control
Completed
This early-stage study tested a new drug, Pociredir (FTX-6058), in 45 adults with sickle cell disease. The main goal was to check safety and how the body processes the drug. Researchers also looked at whether it could increase fetal hemoglobin, which may help reduce painful crise…
Phase: PHASE1 • Sponsor: Fulcrum Therapeutics • Aim: Disease control
Last updated May 01, 2026 16:01 UTC